List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 775 studies with search of: Open Studies | "Insulin"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Not yet recruiting FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Condition: Type 2 Diabetes
Interventions: Drug: "GLIPULIN:" [insulin glargine, metformin, exenatide (GLP-1-agonist)];   Drug: Insulin glargine, metformin, prandial insulin
2 Recruiting Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents
Condition: Diabetes Type 1
Interventions: Drug: insulin Glargine + Insulin Apidra;   Drug: Insulin NPH + Insulin Apidra: Active Comparator
3 Recruiting Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment
Interventions: Drug: saline;   Drug: insulin detemir;   Drug: Insulin
4 Unknown † Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Intervention: Drug: Regular Insulin
5 Not yet recruiting PK/PD Study of Intranasal Insulin in Type I Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Insulin;   Drug: Insulin LISPRO
6 Recruiting Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin Lispro;   Drug: Insulin Aspart
7 Not yet recruiting Cystic Fibrosis (CF) Exacerbation and Insulin Treatment
Conditions: Cystic Fibrosis;   Impaired Glucose Tolerance;   Pulmonary Exacerbation
Interventions: Drug: novorapid / humalog short acting insulin;   Drug: Novo Rapid Insulin (Novonordisk)
8 Recruiting Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use
Condition: Insulin-requiring Type 2 Diabetes Mellitus
Interventions: Drug: nph insulin;   Drug: human insulin;   Drug: Insulin Glargine;   Drug: Insulin glulisine
9 Recruiting Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Technosphere Insulin with MedToneC Inhaler in combination with a basal insulin;   Drug: Technosphere Insulin with Gen2C Inhaler in combination with a basal insulin;   Drug: Insulin Aspart in combination with a basal insulin
10 Recruiting Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE;   Drug: NPH insulin (insulin isophane);   Drug: INSULIN GLULISINE;   Drug: Regular insulin
11 Unknown † Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial
Conditions: Type 2 Diabetes;   Liver Cirrhosis
Interventions: Drug: Glargine & Glulisine;   Drug: Regular insulin;   Drug: NPH & regular insulin
12 Unknown † Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes
Conditions: Type 1 Diabetes;   Hypoglycemia
Interventions: Drug: Evening only administration of insulin glargine;   Drug: Morning only administration of insulin glargine;   Drug: split dose insulin glargine
13 Recruiting Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine
Conditions: Diabetes;   Obesity
Interventions: Drug: insulin Levemir;   Drug: insulin Lantus
14 Recruiting The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
Condition: Diabetes
Interventions: Drug: central insulin;   Drug: Placebo
15 Recruiting Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Gliclazide MR and Insulin Glargine Injection;   Drug: Biosynthetic Human Insulin Injection
16 Recruiting Comparing Long-acting Insulins During Exercise in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glargine;   Drug: Insulin detemir
17 Unknown † The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: insulin glulisine;   Drug: insulin aspart
18 Recruiting Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty
Conditions: Type 2 Diabetes Mellitus;   Peripheral Vascular Disease
Intervention: Drug: Insulin glargine plus insulin analogues
19 Unknown † Veterans Inpatient Insulin Study and Transition to Outpatient Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: NPH/Regular 70/30 mix;   Drug: insulin aspart protamine/insulin aspart 70/30 mix
20 Unknown † Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
Condition: Acute Coronary Syndrome
Interventions: Drug: glucose insulin potassium;   Drug: GIK and intensive insulin therapy

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services